AIMS/HYPOTHESIS: The weak relationship between insulin resistance and total serum triacylglycerols (TGs) could be in part due to heterogeneity of TG molecules and their distribution within different lipoproteins. We determined concentrations of individual TGs and the fatty acid composition of serum and major lipoprotein particles and analysed how changes in different TGs and fatty acid composition are related to features of insulin resistance and abdominal obesity. METHODS: We performed lipidomic analyses of all major lipoprotein fractions using two analytical platforms in 16 individuals, who exhibited a broad range of insulin sensitivity. RESULTS: We identified 45 different TGs in serum. Serum TGs containing saturated and monounsaturated fatty acids were positively, while TGs containing essential linoleic acid (18:2 n-6) were negatively correlated with HOMA-IR. Specific serum TGs that correlated positively with HOMA-IR were also significantly positively related to HOMA-IR when measured in very-low-density lipoproteins (VLDLs), intermediate-density lipoproteins (IDLs) and LDL, but not in HDL subfraction 2 (HDL(2)) or 3 (HDL(3)). Analyses of proportions of esterified fatty acids within lipoproteins revealed that palmitic acid (16:0) was positively related to HOMA-IR when measured in VLDL, IDL and LDL, but not in HDL(2) or HDL(3). Monounsaturated palmitoleic (16:1 n-7) and oleic (18:1 n-9) acids were positively related to HOMA-IR when measured in HDL(2) and HDL(3), but not in VLDL, IDL or LDL. Linoleic acid was negatively related to HOMA-IR in all lipoproteins. CONCLUSIONS/ INTERPRETATION: Serum concentrations of specific TGs, such as TG(16:0/16:0/18:1) or TG(16:0/18:1/18:0), may be more precise markers of insulin resistance than total serum TG concentrations.
AIMS/HYPOTHESIS: The weak relationship between insulin resistance and total serum triacylglycerols (TGs) could be in part due to heterogeneity of TG molecules and their distribution within different lipoproteins. We determined concentrations of individual TGs and the fatty acid composition of serum and major lipoprotein particles and analysed how changes in different TGs and fatty acid composition are related to features of insulin resistance and abdominal obesity. METHODS: We performed lipidomic analyses of all major lipoprotein fractions using two analytical platforms in 16 individuals, who exhibited a broad range of insulin sensitivity. RESULTS: We identified 45 different TGs in serum. Serum TGs containing saturated and monounsaturated fatty acids were positively, while TGs containing essential linoleic acid (18:2 n-6) were negatively correlated with HOMA-IR. Specific serum TGs that correlated positively with HOMA-IR were also significantly positively related to HOMA-IR when measured in very-low-density lipoproteins (VLDLs), intermediate-density lipoproteins (IDLs) and LDL, but not in HDL subfraction 2 (HDL(2)) or 3 (HDL(3)). Analyses of proportions of esterified fatty acids within lipoproteins revealed that palmitic acid (16:0) was positively related to HOMA-IR when measured in VLDL, IDL and LDL, but not in HDL(2) or HDL(3). Monounsaturated palmitoleic (16:1 n-7) and oleic (18:1 n-9) acids were positively related to HOMA-IR when measured in HDL(2) and HDL(3), but not in VLDL, IDL or LDL. Linoleic acid was negatively related to HOMA-IR in all lipoproteins. CONCLUSIONS/ INTERPRETATION: Serum concentrations of specific TGs, such as TG(16:0/16:0/18:1) or TG(16:0/18:1/18:0), may be more precise markers of insulin resistance than total serum TG concentrations.
Authors: Elisa Fabbrini; B Selma Mohammed; Faidon Magkos; Kevin M Korenblat; Bruce W Patterson; Samuel Klein Journal: Gastroenterology Date: 2007-11-28 Impact factor: 22.682
Authors: E Corpeleijn; E J M Feskens; E H J M Jansen; M Mensink; W H M Saris; T W A de Bruin; E E Blaak Journal: Diabetologia Date: 2006-08-03 Impact factor: 10.122
Authors: Kerry L Donnelly; Coleman I Smith; Sarah J Schwarzenberg; Jose Jessurun; Mark D Boldt; Elizabeth J Parks Journal: J Clin Invest Date: 2005-05 Impact factor: 14.808
Authors: J C Lovejoy; C M Champagne; S R Smith; J P DeLany; G A Bray; M Lefevre; Y M Denkins; J C Rood Journal: Metabolism Date: 2001-01 Impact factor: 8.694
Authors: Harmen H M Draisma; Theo H Reijmers; Jacqueline J Meulman; Jan van der Greef; Thomas Hankemeier; Dorret I Boomsma Journal: Eur J Hum Genet Date: 2012-06-20 Impact factor: 4.246
Authors: Santosh Lamichhane; Alex M Dickens; Partho Sen; Heikki Laurikainen; Faith Borgan; Jaana Suvisaari; Tuulia Hyötyläinen; Oliver Howes; Jarmo Hietala; Matej Orešič Journal: Schizophr Bull Date: 2021-01-23 Impact factor: 9.306
Authors: Hemant Kulkarni; Peter J Meikle; Manju Mamtani; Jacquelyn M Weir; Christopher K Barlow; Jeremy B Jowett; Claire Bellis; Thomas D Dyer; Matthew P Johnson; David L Rainwater; Laura Almasy; Michael C Mahaney; Anthony G Comuzzie; John Blangero; Joanne E Curran Journal: Lipids Date: 2013-03-14 Impact factor: 1.880
Authors: Tuija Leskinen; Rita Rinnankoski-Tuikka; Mirva Rintala; Tuulikki Seppänen-Laakso; Eija Pöllänen; Markku Alen; Sarianna Sipilä; Jaakko Kaprio; Vuokko Kovanen; Paavo Rahkila; Matej Oresic; Heikki Kainulainen; Urho M Kujala Journal: PLoS One Date: 2010-09-16 Impact factor: 3.240
Authors: Cassandra E Forsythe; Stephen D Phinney; Richard D Feinman; Brittanie M Volk; Daniel Freidenreich; Erin Quann; Kevin Ballard; Michael J Puglisi; Carl M Maresh; William J Kraemer; Douglas M Bibus; Maria Luz Fernandez; Jeff S Volek Journal: Lipids Date: 2010-09-07 Impact factor: 1.880
Authors: Bryan C Bergman; David Howard; Irene E Schauer; David M Maahs; Janet K Snell-Bergeon; Timothy W Clement; Robert H Eckel; Leigh Perreault; Marian Rewers Journal: J Clin Endocrinol Metab Date: 2012-11-12 Impact factor: 5.958